CJC-1295 (No DAC) + Ipamorelin Blend Technical Overview
CJC-1295 without DAC is commonly called Modified GRF (1-29), a 29-residue, C-terminally amidated GHRH analog. Its reference sequence contains D-Ala², Gln⁸, Ala¹⁵ and Leu²⁷ substitutions. Ipamorelin is a five-residue peptide containing Aib and D-2-Nal, two nonstandard amino-acid building blocks. [1,2]
This formulation combines two separate peptide sequences in one vial. The listed 5mg + 5mg composition is a mass ratio, so it does not imply an equimolar mixture. Component identity and assay response should be assessed separately when designing laboratory comparisons.
Compound Specifications
| Property | Value |
|---|---|
| Compound Class | Two-component synthetic peptide blend |
| Vial Content | 10mg total; 5mg CJC-1295 (No DAC) + 5mg ipamorelin |
| Blend Ratio | 1:1 by component mass |
| CAS Number | CJC-1295 (No DAC) reference peptide: 446036-97-1; ipamorelin: 170851-70-4 |
| PubChem CID | CJC-1295 (No DAC) reference structure: 56841945; ipamorelin: 9831659 |
| Molecular Formula | CJC-1295 (No DAC): C₁₅₂H₂₅₂N₄₄O₄₂; ipamorelin: C₃₈H₄₉N₉O₅ |
| Molecular Weight | CJC-1295 (No DAC): approximately 3367.9 g/mol; ipamorelin: approximately 711.9 g/mol |
| Synonyms | CJC-1295 (No DAC): Modified GRF (1-29), Mod GRF 1-29; ipamorelin: NNC 26-0161 |
| CJC-1295 (No DAC) Sequence | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂; Y-(D-Ala)-DAIFTQSYRKVLAQLSARKLLQDILSR-NH₂ |
| Ipamorelin Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NH₂ |
| Sequence Length | CJC-1295 (No DAC): 29 residues; ipamorelin: 5 residues |
| Source | Synthetic peptides |
| InChIKey | CJC-1295 (No DAC) reference structure: XOZMWINMZMMOBR-HRDSVTNWSA-N; ipamorelin: NEHWBYHLYZGBNO-BVEPWEIPSA-N |
| Purity | ≥99%, as specified on the product listing; UHPLC-MS testing |
| Appearance | Lyophilized powder in a vial |
| Solubility | Qualify solvent compatibility and dissolved-component recovery for the assay |
| Storage | Lyophilized material at −20°C; protect from light and moisture |
Storage and Handling
- Store the sealed lyophilized vial at −20°C, protected from light and moisture.
- After reconstitution, follow the validated storage conditions for your assay and use promptly.
- Maintain aseptic handling and avoid repeated freeze-thaw cycles.
Lyophilized Format
This compound ships in lyophilized (freeze-dried) form. Freeze-drying supports long-term storage stability and preserves compound integrity. No fillers are added.
Research Use Disclaimer
CJC-1295 (No DAC) & Ipamorelin Blend is supplied for research use only. It is not a drug, food, cosmetic, or dietary supplement and has not been evaluated by the FDA. By purchasing, the buyer confirms the compound will be used solely for in vitro research.
Frequently Asked Questions
What Is in the CJC-1295 Ipamorelin 10mg Blend?
The CJC-1295 Ipamorelin 10mg blend contains 5mg CJC-1295 without DAC and 5mg ipamorelin in one lyophilized vial. The 1:1 ratio describes component mass, rather than equal numbers of molecules.
What Does No DAC Mean in This Peptide Blend?
CJC-1295 without DAC is the 29-residue Modified GRF (1-29) peptide without the added albumin-binding DAC group. The no-DAC and DAC constructs have different chemical identities.
Does the CJC-1295 Ipamorelin Blend Have One Molecular Weight?
The CJC-1295 Ipamorelin blend contains two separate peptides with reference molecular weights of approximately 3367.9 g/mol and 711.9 g/mol, respectively. A single molecular weight does not describe this mixture.
What Testing Documentation Is Available for the Blend?
BioLongevity Labs lists third-party UHPLC-MS testing, a ≥99% purity specification and an available Certificate of Analysis for the CJC-1295 Ipamorelin blend. Review the applicable lot report for the reported analytical results.
Related Products
Browse more in On Sale.













Reviews
There are no reviews yet.